Sonnet Biotherapeutics Holdings Inc (SONN) |
|
2.555 -0.025 (-0.97%)
|
11-27 12:48 |
|
Open: |
2.56 |
Pre. Close: |
2.58 |
|
High:
|
2.57 |
Low:
|
2.48 |
|
Volume:
|
408,087 |
Market Cap:
|
36M |
|
|
|
|
Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.723 - 2.737 |
2.737 - 2.75 |
|
Low:
|
2.483 - 2.499 |
2.499 - 2.514 |
|
Close:
|
2.55 - 2.576 |
2.576 - 2.601 |
|
Technical analysis |
as of: 2020-11-27 12:24:37 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 3.10 One year: 3.35 |
| Support: |
Support1: 2.30 Support2: 1.91 |
| Resistance: |
Resistance1: 2.65 Resistance2: 2.87 |
| Pivot: |
2.48 |
| Moving Average: |
MA(5): 2.51  MA(20): 2.51
MA(100): 2.77 MA(250): 7.30 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 66.85 %D(3): 57.76 |
| RSI: |
RSI(14): 50.13 |
| 52-week: |
High: 54.60 Low: 2.23 Change(%): -85.6 |
| Average Vol(K): |
3-Month: 61883 10-Days: 85702 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.SONN has closed below upper band by 23.5%. Bollinger Bands are 69.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to SONN's normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 27 Nov 2020
Is Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) a Suitable Stock for New Investors Now? - Stocks Register
Thu, 26 Nov 2020
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) stock market valuation reached $35.89 million - BOV News
Wed, 25 Nov 2020
Sonnet BioTherapeutics Holdings Inc. (SONN) distance from 20-day Simple moving Average is 2.94%: What to Expect? - The InvestChronicle
Sat, 14 Nov 2020
Is Sonnet BioTherapeutics Holdings, Inc.(NASDAQ:SONN) Stock Good For Medium-Term Investing? - Stocks Register
Fri, 09 Oct 2020
Sonnet BioTherapeutics Holdings Inc. [SONN] is -80.64% lower this YTD. Is it still time to buy? - The DBT News
Tue, 25 Aug 2020
Sonnet BioTherapeutics Holdings Inc. [SONN] is -74.58% lower this YTD. Is it still time to buy? - The DBT News
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
|
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
